Knowledge

Trovafloxacin

Source ๐Ÿ“

342: 572: 749:, and sparked significant public outcry. The most serious error was the falsification and backdating of an ethics approval letter by the lead investigator of the trial, Dr. Abdulhamid Isa Dutse. Dr. Dutse is now the chief medical officer of Aminu Kano Teaching Hospital. The result of the trial was that children treated with oral trovafloxacin had a 5% (5/100) mortality rate compared to a 6% (6/100) mortality rate with intramuscular ceftriaxone. 727:, the drug was administered to approximately 200 infected children. Eleven children died in the trial: five after taking Trovan and six after taking an older antibiotic used for comparison in the clinical trial. Others suffered blindness, deafness and brain damage, common consequences of meningitis that have not been seen in patients treated with trovafloxacin for other infection types. An investigation by the Washington Post concluded that 29: 768:. A US$ 75 million settlement with the State of Kano was reached on July 30, 2009. Additionally two lawsuits also remain pending in New York, United States. According to Wikileaked US embassy cables, Pfizer's country manager admitted that "Pfizer had hired investigators to uncover corruption links to federal attorney general Michael Aondoakaa to expose him and put pressure on him to drop the federal cases." 681:
The U.S. Food and Drug Administration approved trovafloxacin for therapeutic use in December 1997 for use in patients aged 18 years and older. In June 1999, the agency advised doctors to limit the prescription of trovafloxacin due to adverse events associated with the drug (over 100 cases of acute
689:
recommended suspension of the marketing authorisation for a year. The suspension took effect in August 1999 and was renewed in September 2000. In October 2000, Pfizer notified the European Commission of its decision to voluntarily withdraw the marketing authorisation which was approved by EMA in
1258: 562:
Trovafloxacin use is significantly restricted due to its high potential for inducing serious and sometimes fatal liver damage. Currently, the drug is not approved for use in the U.S. or the European Union due to association with cases of acute liver failure and death.
1255: 698:
Trovan sales during its first full year on the market contributed US$ 160 million of Pfizer's total revenue of US$ 12.6 billion. Investors expected it to eventually bring in US$ 1 billion per year.
421: 664:
reaction, this amine is then used to displace the more reactive fluorine at the 7-position in Ethyl 1-(2,4-difluorophenyl)-6,7-difluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate (
936: 1647: 463:
InChI=1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16+
1642: 1443: 809:"Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro" 85: 609:
results in loss of nitrogen and formation of the cyclopropylpyrrolidine ring. The stereochemistry of the ring simply reflects the thermodynamics, since
479: 1289: 650: 598: 1592: 1149:
Sabatini C, Bosis S, Semino M, Senatore L, Principi N, Esposito S (June 2012). "Clinical presentation of meningococcal disease in childhood".
983: 41: 685:
Trovafloxacin received marketing authorisation in the European Union in October 1998. In June 1999, in view of reported adverse events, the
2264: 686: 435: 963: 1004: 638: 2185: 1282: 2229: 1396: 753: 707: 486: 1208: 1177: 2279: 1341: 1024: 455: 2202: 1485: 1275: 1234: 908: 1046: 1065:
Williams D, Hopkins S (June 1998). "Safety of trovafloxacin in treatment of lower respiratory tract infections".
139: 115: 2259: 2074: 1891: 1777: 1632: 1843: 1720: 1406: 1048:
Report of the Investigation Committee on the Clinical Trial of Trovafloxacin (Trovan) by Pfizer, Kano, 1996.
2121: 1513: 916: 756:
in the United States. However, in January 2009, the United States Court of Appeals for the Second Circuit
241: 1963: 743:
from the children's parents. The case came to light in December 2000 as the result of an investigation by
937:"Public statement on Trovan / Trovan IV / Turvel / Turvel IV: Withdrawal of the marketing authorisations" 321: 1267: 682:
liver injury reported to FDA). In May 2000, the FDA withdrew marketing authorisation for trovafloxacin.
147:
7-(6-Amino-3-azabicyclohex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo- naphthyridine-3-carboxylic acid
310: 2254: 2249: 944: 617:
configuration of the ester group. The ester is then saponified to the corresponding carboxylic acid (
586: 2239: 1637: 626: 337: 856:
Pannu HK, Gottlieb L, Fishman EK (2001). "Acute liver failure due to trovafloxacin: CT findings".
807:
Gootz TD, Zaniewski R, Haskell S, Schmieder B, Tankovic J, Girard D, et al. (December 1996).
2244: 2190: 1698: 646: 73: 2269: 1546: 1391: 1302: 230: 2234: 1469: 1465: 1349: 736: 622: 512: 290: 165: 1768: 1692: 787: 250: 8: 1818: 1182: 745: 156: 341: 2069: 1541: 1090: 988: 968: 873: 765: 590: 833: 808: 1325: 1158: 1131: 1082: 1020: 838: 65: 877: 1814: 1521: 1493: 1121: 1094: 1074: 1012: 865: 828: 820: 653: 551: 358: 98: 190: 2274: 1710: 1536: 1262: 760:
that the Nigerian victims and their families were entitled to bring suit against
1310: 1306: 51: 2196: 2083: 1953: 1753: 1748: 1738: 1602: 1597: 1561: 1419: 1016: 777: 732: 539: 757: 577: 20: 2223: 2051: 2001: 1991: 1939: 1929: 1861: 1785: 1743: 1663: 1587: 1556: 1475: 1461: 1449: 1439: 1433: 1429: 1424: 1414: 1369: 1235:"WikiLeaks cables: Pfizer 'used dirty tricks to avoid clinical trial payout'" 547: 543: 535: 2006: 1996: 1981: 1971: 1944: 1924: 1919: 1914: 1909: 1904: 1899: 1881: 1876: 1871: 1866: 1856: 1851: 1810: 1805: 1607: 1498: 1379: 1162: 1135: 824: 520: 93: 1086: 842: 571: 2167: 2159: 2139: 2092: 2026: 1986: 1934: 1823: 1673: 1612: 1566: 1526: 1503: 1374: 1354: 1298: 1297: 752:
Between 2002 and 2005 the victims of the Trovan tests in Nigeria filed a
720: 594: 59: 1209:"Pfizer to Pay $ 75 Million to Settle Nigerian Trovan Drug-Testing Suit" 210: 2129: 2055: 2042: 2031: 1976: 1833: 1828: 1800: 1733: 1703: 1551: 1364: 1319: 1078: 869: 713: 531: 516: 397: 221: 1110:"Fluoroquinolone toxicity profiles: a review focusing on newer agents" 2149: 2144: 2134: 2116: 1790: 1758: 1728: 1678: 1531: 1454: 661: 606: 176: 45: 1795: 1582: 1359: 1126: 1109: 1067:
European Journal of Clinical Microbiology & Infectious Diseases
716: 527: 270: 201: 420: 1668: 781: 740: 724: 28: 761: 728: 634: 504: 301: 806: 613:
ring fusion is by far the most stable arrangement, as is the
411: 281: 326: 1148: 261: 1256:
Abdullahi v Pfizer. US Court of Appeals 2d Cir 30 Jan 2009
2106: 2082: 909:"Trovafloxacin โ€“ Approval Letter & Printed Labelling" 523: 538:
IV. It was withdrawn from the market due to the risk of
1178:"Panel Faults Pfizer in '96 Clinical Trial In Nigeria" 701: 637:
from the reaction medium to afford the product as its
855: 443:
O=C(O)C2=CN(c1nc(c(F)cc1C2=O)N3C4(N)4C3)c5ccc(F)cc5F
585:The key reaction in building the ring consists of 1202: 1200: 1009:The SAGE Encyclopedia of Pharmacology and Society 2221: 964:"Unforeseen Side Effects Ruined One Blockbuster" 731:had administered the drug as part of an illegal 189: 1064: 784:of trovafloxacin for intravenous administration 164: 1197: 1011:. SAGE Publications, Inc. pp. 1444โ€“1447. 984:"Suspension of Trovan Drug in Europe Is Urged" 1283: 687:Committee for Proprietary Medicinal Products 1107: 629:(DPPA) to afford the transient isocyanate ( 1290: 1276: 1151:Journal of Preventive Medicine and Hygiene 340: 229: 1125: 832: 249: 1206: 1175: 961: 575:Trovafloxacin synthesis: K. E. Brighty, 570: 52:Micromedex Detailed Consumer Information 1232: 892:The organic chemistry of Drug Synthesis 621:). The acid undergoes a version of the 336: 209: 64: 2222: 1002: 957: 955: 671: 639:tert-Butyloxycarbonyl protecting group 1271: 1108:Lipsky BA, Baker CA (February 1999). 1054:, Federal Ministry of Health, Nigeria 813:Antimicrobial Agents and Chemotherapy 309: 289: 50: 1005:"Trovafloxacin (Trovan) Controversy" 931: 929: 927: 557: 97: 2265:Heterocyclic compounds with 2 rings 976: 952: 708:Kano Trovafloxacin trial litigation 702:Nigerian clinical trial controversy 269: 180: 13: 1169: 14: 2291: 1249: 924: 566: 381: 375: 369: 27: 1226: 1142: 1101: 1058: 764:in the United States under the 754:series of unsuccessful lawsuits 735:without authorization from the 676: 656:to afford the secondary amine ( 519:that inhibits the uncoiling of 468:Key:WVPSKSLAZQPAKQ-CDMJZVDBSA-N 1039: 996: 962:Petersen M (August 27, 2000). 901: 884: 849: 800: 633:). The reactive function adds 387: 363: 1: 1633:Trimethoprim/sulfamethoxazole 1233:Boseley S (9 December 2010). 992:. June 12, 1999. p. C.3. 793: 1207:Stephens J (July 31, 2009). 1114:Clinical Infectious Diseases 917:Food and Drug Administration 693: 546:bacterial coverage but less 530:by blocking the activity of 7: 2230:Fluoroquinolone antibiotics 1638:Ormetoprim/sulfadimethoxine 771: 550:coverage than the previous 10: 2296: 1176:Stephens J (May 7, 2006). 1017:10.4135/9781483349985.n409 705: 353:Chemical and physical data 2280:Fluorobenzene derivatives 2180: 2158: 2115: 2105: 2068: 2040: 2019: 1962: 1890: 1842: 1776: 1767: 1719: 1691: 1656: 1648:Pyrimethamine/sulfadoxine 1625: 1575: 1512: 1484: 1405: 1390: 1340: 1318: 945:European Medicines Agency 587:1,3-Dipolar cycloaddition 476: 451: 431: 409: 396: 357: 352: 320: 300: 280: 260: 240: 220: 200: 175: 155: 135: 130: 114: 109: 84: 72: 58: 40: 35: 26: 627:diphenylphosphoryl azide 647:Catalytic hydrogenation 1547:Sulfamethoxypyridazine 825:10.1128/AAC.40.12.2691 582: 515:) is a broad spectrum 2260:Nitrogen heterocycles 2020:Newer non-fluorinated 1657:Other DHPS inhibitors 1643:Pyrimethamine/dapsone 1470:Succinylsulfathiazole 1466:Phthalylsulfathiazole 1350:2,4-Diaminopyrimidine 623:Curtius rearrangement 578:U.S. patent 5,164,402 574: 513:Laboratorios Almirall 123:Withdrawn from market 1444:Acetyl sulfisoxazole 1303:inhibit nucleic acid 1261:13 June 2011 at the 1819:Alalevonadifloxacin 1486:Intermediate-acting 1213:The Washington Post 1183:The Washington Post 858:Emergency Radiology 746:The Washington Post 737:Nigerian government 672:Society and culture 23: 2207:Never to phase III 1708:thereby inhibiting 1696:(inhibit bacterial 1542:Sulfametoxydiazine 1330:thereby inhibiting 1323:(inhibit bacterial 1079:10.1007/bf01691582 989:The New York Times 969:The New York Times 870:10.1007/PL00011876 766:Alien Tort Statute 712:In 1996, during a 625:when treated with 591:ethyl diazoacetate 583: 19: 2217: 2216: 2176: 2175: 2101: 2100: 2064: 2063: 2015: 2014: 1687: 1686: 1621: 1620: 1326:purine metabolism 1003:Oldani M (2016). 819:(12): 2691โ€“2697. 660:). In a standard 649:then removes the 581:(1992 to Pfizer). 558:Adverse reactions 494: 493: 422:Interactive image 322:CompTox Dashboard 80:Oral, intravenous 2287: 2255:Aromatic ketones 2250:Alpha-keto acids 2113: 2112: 2080: 2079: 1815:Levonadifloxacin 1774: 1773: 1769:Fluoroquinolones 1717: 1716: 1522:Sulfadimethoxine 1494:Sulfamethoxazole 1415:Sulfaisodimidine 1403: 1402: 1338: 1337: 1292: 1285: 1278: 1269: 1268: 1243: 1242: 1230: 1224: 1223: 1221: 1219: 1204: 1195: 1194: 1192: 1191: 1173: 1167: 1166: 1146: 1140: 1139: 1129: 1105: 1099: 1098: 1062: 1056: 1055: 1053: 1043: 1037: 1036: 1034: 1033: 1000: 994: 993: 980: 974: 973: 959: 950: 949: 941: 933: 922: 921: 913: 905: 899: 888: 882: 881: 853: 847: 846: 836: 804: 654:protecting group 580: 552:fluoroquinolones 542:. It had better 490: 489: 482: 424: 404: 389: 383: 377: 371: 365: 345: 344: 330: 328: 313: 293: 273: 253: 233: 213: 193: 183: 182: 168: 101: 68: 54: 31: 24: 22: 18: 2295: 2294: 2290: 2289: 2288: 2286: 2285: 2284: 2240:Withdrawn drugs 2220: 2219: 2218: 2213: 2212: 2197:Clinical trials 2172: 2154: 2120: 2097: 2073: 2060: 2036: 2011: 1958: 1886: 1838: 1763: 1711:DNA replication 1709: 1707: 1701: 1697: 1695: 1683: 1652: 1617: 1576:Other/ungrouped 1571: 1537:Sulfametomidine 1508: 1480: 1394: 1386: 1333: 1331: 1329: 1324: 1322: 1314: 1296: 1263:Wayback Machine 1252: 1247: 1246: 1231: 1227: 1217: 1215: 1205: 1198: 1189: 1187: 1174: 1170: 1147: 1143: 1106: 1102: 1063: 1059: 1051: 1045: 1044: 1040: 1031: 1029: 1027: 1001: 997: 982: 981: 977: 972:. p. 3.11. 960: 953: 939: 935: 934: 925: 911: 907: 906: 902: 898:, p 123 (1995). 889: 885: 854: 850: 805: 801: 796: 774: 710: 704: 696: 679: 674: 576: 569: 560: 485: 483: 480:(what is this?) 477: 472: 469: 464: 459: 458: 447: 444: 439: 438: 427: 402: 392: 386: 380: 374: 368: 348: 324: 316: 296: 276: 256: 236: 216: 196: 179: 171: 151: 148: 143: 142: 126: 105: 75: 17: 12: 11: 5: 2293: 2283: 2282: 2277: 2272: 2267: 2262: 2257: 2252: 2247: 2245:Naphthyridines 2242: 2237: 2232: 2215: 2214: 2211: 2210: 2209: 2208: 2205: 2194: 2188: 2182: 2181: 2178: 2177: 2174: 2173: 2171: 2170: 2164: 2162: 2156: 2155: 2153: 2152: 2147: 2142: 2137: 2132: 2126: 2124: 2122:RNA polymerase 2110: 2103: 2102: 2099: 2098: 2096: 2095: 2089: 2087: 2084:Nitroimidazole 2077: 2066: 2065: 2062: 2061: 2059: 2058: 2052:Aminocoumarins 2048: 2046: 2038: 2037: 2035: 2034: 2029: 2023: 2021: 2017: 2016: 2013: 2012: 2010: 2009: 2004: 1999: 1994: 1989: 1984: 1979: 1974: 1968: 1966: 1960: 1959: 1957: 1956: 1954:Alatrofloxacin 1947: 1942: 1937: 1932: 1927: 1922: 1917: 1912: 1907: 1902: 1896: 1894: 1892:4th generation 1888: 1887: 1885: 1884: 1879: 1874: 1869: 1864: 1859: 1854: 1848: 1846: 1844:3rd generation 1840: 1839: 1837: 1836: 1831: 1826: 1821: 1808: 1803: 1798: 1793: 1788: 1782: 1780: 1778:2nd generation 1771: 1765: 1764: 1762: 1761: 1756: 1754:Piromidic acid 1751: 1749:Pipemidic acid 1746: 1741: 1739:Nalidixic acid 1736: 1731: 1725: 1723: 1721:1st generation 1714: 1689: 1688: 1685: 1684: 1682: 1681: 1676: 1671: 1666: 1660: 1658: 1654: 1653: 1651: 1650: 1645: 1640: 1635: 1629: 1627: 1623: 1622: 1619: 1618: 1616: 1615: 1610: 1605: 1603:Sulfaguanidine 1600: 1598:Sulfadicramide 1595: 1590: 1585: 1579: 1577: 1573: 1572: 1570: 1569: 1564: 1562:Sulfaphenazole 1559: 1554: 1549: 1544: 1539: 1534: 1529: 1524: 1518: 1516: 1510: 1509: 1507: 1506: 1501: 1496: 1490: 1488: 1482: 1481: 1479: 1478: 1473: 1459: 1458: 1457: 1447: 1437: 1427: 1422: 1420:Sulfamethizole 1417: 1411: 1409: 1400: 1397:DHPS inhibitor 1388: 1387: 1385: 1384: 1383: 1382: 1377: 1372: 1367: 1362: 1357: 1346: 1344: 1342:DHFR inhibitor 1335: 1316: 1315: 1299:Antibacterials 1295: 1294: 1287: 1280: 1272: 1266: 1265: 1251: 1250:External links 1248: 1245: 1244: 1225: 1196: 1168: 1157:(2): 116โ€“119. 1141: 1127:10.1086/515104 1120:(2): 352โ€“364. 1100: 1073:(6): 454โ€“458. 1057: 1038: 1025: 995: 975: 951: 923: 900: 883: 864:(2): 108โ€“110. 848: 798: 797: 795: 792: 791: 790: 785: 778:Alatrofloxacin 773: 770: 733:clinical trial 706:Main article: 703: 700: 695: 692: 678: 675: 673: 670: 651:carbobenzyloxy 597:to afford the 568: 565: 559: 556: 540:hepatotoxicity 492: 491: 474: 473: 471: 470: 467: 465: 462: 454: 453: 452: 449: 448: 446: 445: 442: 434: 433: 432: 429: 428: 426: 425: 417: 415: 407: 406: 400: 394: 393: 390: 384: 378: 372: 366: 361: 355: 354: 350: 349: 347: 346: 333: 331: 318: 317: 315: 314: 306: 304: 298: 297: 295: 294: 286: 284: 278: 277: 275: 274: 266: 264: 258: 257: 255: 254: 246: 244: 238: 237: 235: 234: 226: 224: 218: 217: 215: 214: 206: 204: 198: 197: 195: 194: 186: 184: 173: 172: 170: 169: 161: 159: 153: 152: 150: 149: 146: 138: 137: 136: 133: 132: 128: 127: 125: 124: 120: 118: 112: 111: 107: 106: 104: 103: 90: 88: 82: 81: 78: 76:administration 70: 69: 62: 56: 55: 48: 38: 37: 33: 32: 15: 9: 6: 4: 3: 2: 2292: 2281: 2278: 2276: 2273: 2271: 2270:Cyclopropanes 2268: 2266: 2263: 2261: 2258: 2256: 2253: 2251: 2248: 2246: 2243: 2241: 2238: 2236: 2233: 2231: 2228: 2227: 2225: 2206: 2204: 2201: 2200: 2198: 2195: 2192: 2189: 2187: 2184: 2183: 2179: 2169: 2166: 2165: 2163: 2161: 2157: 2151: 2148: 2146: 2143: 2141: 2138: 2136: 2133: 2131: 2128: 2127: 2125: 2123: 2118: 2114: 2111: 2108: 2104: 2094: 2091: 2090: 2088: 2085: 2081: 2078: 2076: 2071: 2067: 2057: 2053: 2050: 2049: 2047: 2044: 2039: 2033: 2030: 2028: 2025: 2024: 2022: 2018: 2008: 2005: 2003: 2002:Pradofloxacin 2000: 1998: 1995: 1993: 1992:Marbofloxacin 1990: 1988: 1985: 1983: 1980: 1978: 1975: 1973: 1970: 1969: 1967: 1965: 1961: 1955: 1951: 1950:Trovafloxacin 1948: 1946: 1943: 1941: 1940:Prulifloxacin 1938: 1936: 1933: 1931: 1930:Clinafloxacin 1928: 1926: 1923: 1921: 1918: 1916: 1913: 1911: 1908: 1906: 1903: 1901: 1898: 1897: 1895: 1893: 1889: 1883: 1880: 1878: 1875: 1873: 1870: 1868: 1865: 1863: 1862:Grepafloxacin 1860: 1858: 1855: 1853: 1850: 1849: 1847: 1845: 1841: 1835: 1832: 1830: 1827: 1825: 1822: 1820: 1816: 1812: 1809: 1807: 1804: 1802: 1799: 1797: 1794: 1792: 1789: 1787: 1786:Ciprofloxacin 1784: 1783: 1781: 1779: 1775: 1772: 1770: 1766: 1760: 1757: 1755: 1752: 1750: 1747: 1745: 1744:Oxolinic acid 1742: 1740: 1737: 1735: 1732: 1730: 1727: 1726: 1724: 1722: 1718: 1715: 1712: 1705: 1700: 1699:topoisomerase 1694: 1690: 1680: 1677: 1675: 1672: 1670: 1667: 1665: 1664:Acediasulfone 1662: 1661: 1659: 1655: 1649: 1646: 1644: 1641: 1639: 1636: 1634: 1631: 1630: 1628: 1624: 1614: 1611: 1609: 1606: 1604: 1601: 1599: 1596: 1594: 1591: 1589: 1588:Sulfacetamide 1586: 1584: 1581: 1580: 1578: 1574: 1568: 1565: 1563: 1560: 1558: 1557:Sulfamerazine 1555: 1553: 1550: 1548: 1545: 1543: 1540: 1538: 1535: 1533: 1530: 1528: 1525: 1523: 1520: 1519: 1517: 1515: 1511: 1505: 1502: 1500: 1497: 1495: 1492: 1491: 1489: 1487: 1483: 1477: 1476:Sulfathiourea 1474: 1471: 1467: 1463: 1462:Sulfathiazole 1460: 1456: 1453: 1452: 1451: 1450:Sulfanilamide 1448: 1445: 1441: 1440:Sulfafurazole 1438: 1435: 1434:Sulfasalazine 1431: 1430:Sulfapyridine 1428: 1426: 1425:Sulfadimidine 1423: 1421: 1418: 1416: 1413: 1412: 1410: 1408: 1404: 1401: 1398: 1393: 1389: 1381: 1378: 1376: 1373: 1371: 1370:Pyrimethamine 1368: 1366: 1363: 1361: 1358: 1356: 1353: 1352: 1351: 1348: 1347: 1345: 1343: 1339: 1336: 1327: 1321: 1317: 1312: 1308: 1304: 1300: 1293: 1288: 1286: 1281: 1279: 1274: 1273: 1270: 1264: 1260: 1257: 1254: 1253: 1240: 1236: 1229: 1214: 1210: 1203: 1201: 1186:. p. A01 1185: 1184: 1179: 1172: 1164: 1160: 1156: 1152: 1145: 1137: 1133: 1128: 1123: 1119: 1115: 1111: 1104: 1096: 1092: 1088: 1084: 1080: 1076: 1072: 1068: 1061: 1050: 1049: 1042: 1028: 1026:9781483350004 1022: 1018: 1014: 1010: 1006: 999: 991: 990: 985: 979: 971: 970: 965: 958: 956: 947: 946: 938: 932: 930: 928: 919: 918: 910: 904: 897: 893: 890:D. Lednicer, 887: 879: 875: 871: 867: 863: 859: 852: 844: 840: 835: 830: 826: 822: 818: 814: 810: 803: 799: 789: 786: 783: 779: 776: 775: 769: 767: 763: 759: 755: 750: 748: 747: 742: 738: 734: 730: 726: 722: 718: 715: 709: 699: 691: 688: 683: 669: 667: 663: 659: 655: 652: 648: 644: 640: 636: 632: 628: 624: 620: 616: 612: 608: 604: 600: 599:pyrrazolidine 596: 592: 588: 579: 573: 567:Manufacturing 564: 555: 553: 549: 548:Gram-negative 545: 544:Gram-positive 541: 537: 536:topoisomerase 533: 529: 525: 522: 518: 514: 510: 506: 502: 498: 497:Trovafloxacin 488: 481: 475: 466: 461: 460: 457: 450: 441: 440: 437: 430: 423: 419: 418: 416: 413: 408: 401: 399: 395: 362: 360: 356: 351: 343: 339: 338:DTXSID0041145 335: 334: 332: 323: 319: 312: 308: 307: 305: 303: 299: 292: 288: 287: 285: 283: 279: 272: 268: 267: 265: 263: 259: 252: 248: 247: 245: 243: 239: 232: 228: 227: 225: 223: 219: 212: 208: 207: 205: 203: 199: 192: 188: 187: 185: 178: 174: 167: 163: 162: 160: 158: 154: 145: 144: 141: 134: 129: 122: 121: 119: 117: 113: 108: 100: 95: 92: 91: 89: 87: 83: 79: 77: 71: 67: 63: 61: 57: 53: 49: 47: 43: 39: 36:Clinical data 34: 30: 25: 21:Trovafloxacin 2235:Hepatotoxins 2160:Lipiarmycins 2007:Sarafloxacin 1997:Orbifloxacin 1982:Enrofloxacin 1972:Danofloxacin 1949: 1945:Sitafloxacin 1925:Moxifloxacin 1920:Gemifloxacin 1915:Finafloxacin 1910:Gatifloxacin 1905:Delafloxacin 1900:Besifloxacin 1882:Tosufloxacin 1877:Temafloxacin 1872:Sparfloxacin 1867:Pazufloxacin 1857:Balofloxacin 1852:Levofloxacin 1811:Nadifloxacin 1806:Lomefloxacin 1626:Combinations 1608:Sulfametrole 1593:Sulfaclozine 1499:Sulfadiazine 1407:Short-acting 1392:Sulfonamides 1380:Trimethoprim 1239:The Guardian 1238: 1228: 1216:. Retrieved 1212: 1188:. Retrieved 1181: 1171: 1154: 1150: 1144: 1117: 1113: 1103: 1070: 1066: 1060: 1047: 1041: 1030:. Retrieved 1008: 998: 987: 978: 967: 943: 915: 903: 895: 891: 886: 861: 857: 851: 816: 812: 802: 751: 744: 711: 697: 690:March 2001. 684: 680: 677:Legal status 665: 657: 642: 641:derivative ( 630: 618: 614: 610: 602: 584: 561: 508: 500: 496: 495: 484:   478:   116:Legal status 110:Legal status 2193:from market 2168:Fidaxomicin 2140:Rifapentine 2093:Secnidazole 2086:derivatives 2027:Nemonoxacin 1987:Ibafloxacin 1935:Garenoxacin 1824:Norfloxacin 1674:Solasulfone 1613:Sulfanitran 1567:Sulfamazone 1527:Sulfadoxine 1514:Long-acting 1504:Sulfamoxole 1375:Tetroxoprim 1355:Brodimoprim 1332:DNA and RNA 1320:Antifolates 595:3-pyrroline 526:in various 521:supercoiled 405: gยทmol 166:147059-72-1 131:Identifiers 60:MedlinePlus 2224:Categories 2130:Rifampicin 2117:Rifamycins 2075:inhibitors 2056:Novobiocin 2032:Ozenoxacin 1977:Difloxacin 1964:Veterinary 1834:Rufloxacin 1829:Pefloxacin 1801:Fleroxacin 1734:Flumequine 1704:DNA gyrase 1693:Quinolones 1552:Sulfaperin 1365:Ormetoprim 1334:synthesis) 1190:2006-08-28 1032:2019-01-21 794:References 714:meningitis 532:DNA gyrase 517:antibiotic 410:3D model ( 398:Molar mass 291:CHEBI:9763 251:9F388J00UK 222:ChemSpider 157:CAS Number 140:IUPAC name 16:Antibiotic 2203:Phase III 2191:Withdrawn 2150:Rifalazil 2145:Rifaximin 2135:Rifabutin 2109:synthesis 2070:Anaerobic 2041:Related ( 1791:Ofloxacin 1759:Rosoxacin 1729:Cinoxacin 1679:Sulfoxone 1532:Sulfalene 1455:Prontosil 788:Quinolone 694:Economics 662:quinoline 607:Pyrolysis 593:to N-Cbz- 499:(sold as 311:ChEMBL428 74:Routes of 46:Drugs.com 1796:Enoxacin 1583:Mafenide 1360:Iclaprim 1259:Archived 1163:23240173 1136:10064255 878:43307678 772:See also 717:epidemic 528:bacteria 487:(verify) 231:16736478 202:DrugBank 86:ATC code 1702:and/or 1669:Dapsone 1218:May 26, 1095:1325773 1087:9758292 843:9124824 782:prodrug 741:consent 725:Nigeria 403:416.360 359:Formula 211:DB00685 177:PubChem 102:) 96: ( 94:J01MA13 66:a605016 2275:Amines 2186:WHO-EM 1161:  1134:  1093:  1085:  1023:  896:Vol. 5 876:  841:  834:163605 831:  762:Pfizer 729:Pfizer 635:t-BuOH 509:Turvel 505:Pfizer 501:Trovan 436:SMILES 302:ChEMBL 271:D08654 1301:that 1091:S2CID 1052:(PDF) 940:(PDF) 912:(PDF) 874:S2CID 758:ruled 456:InChI 412:JSmol 282:ChEBI 191:62959 1311:J01M 1307:J01E 1220:2010 1159:PMID 1132:PMID 1083:PMID 1021:ISBN 839:PMID 780:, a 721:Kano 534:and 507:and 262:KEGG 242:UNII 42:AHFS 2107:RNA 2072:DNA 1122:doi 1075:doi 1013:doi 866:doi 829:PMC 821:doi 739:or 719:in 668:). 645:). 615:cis 611:cis 605:). 589:of 524:DNA 511:by 503:by 327:EPA 181:CID 99:WHO 2226:: 2199:: 2054:: 2043:DG 1468:, 1309:, 1237:. 1211:. 1199:^ 1180:. 1155:53 1153:. 1130:. 1118:28 1116:. 1112:. 1089:. 1081:. 1071:17 1069:. 1019:. 1007:. 986:. 966:. 954:^ 942:. 926:^ 914:. 894:, 872:. 860:. 837:. 827:. 817:40 815:. 811:. 723:, 554:. 373:15 367:20 2119:/ 2045:) 1952:/ 1817:/ 1813:/ 1713:) 1706:, 1472:) 1464:( 1446:) 1442:( 1436:) 1432:( 1399:) 1395:( 1328:, 1313:) 1305:( 1291:e 1284:t 1277:v 1241:. 1222:. 1193:. 1165:. 1138:. 1124:: 1097:. 1077:: 1035:. 1015:: 948:. 920:. 880:. 868:: 862:8 845:. 823:: 666:9 658:8 643:7 631:6 619:5 603:3 601:( 414:) 391:3 388:O 385:4 382:N 379:3 376:F 370:H 364:C 329:) 325:( 44:/

Index


AHFS
Drugs.com
Micromedex Detailed Consumer Information
MedlinePlus
a605016
Routes of
administration

ATC code
J01MA13
WHO
Legal status
IUPAC name
CAS Number
147059-72-1
PubChem
62959
DrugBank
DB00685
ChemSpider
16736478
UNII
9F388J00UK
KEGG
D08654
ChEBI
CHEBI:9763
ChEMBL
ChEMBL428
CompTox Dashboard
DTXSID0041145

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

โ†‘